Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis
Autores da FMUP
Participantes de fora da FMUP
- Rubin, David T.
- Kubassova, Olga
- Weber, Christopher R.
- Adsul, Shashi
- Freire, Marcelo
- Biedermann, Luc
- Koelzer, Viktor H.
- Bressler, Brian
- Xiong, Wei
- Niess, Jan H.
- Matter, Matthias S.
- Kopylov, Uri
- Barshack, Iris
- Mayer, Chen
- Maharshak, Nitsan
- Greenberg, Ariel
- Hart, Simon
- Dehmeshki, Jamshid
- Peyrin-Biroulet, Laurent
Unidades de investigação
Abstract
Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by increased stool frequency, rectal bleeding, and urgency. To streamline the quantitative assessment of histopathology using the Nancy Index in UC patients, we developed a novel artificial intelligence (AI) tool based on deep learning and tested it in a proof-of-concept trial. In this study, we report the performance of a modified version of the AI tool.Methods Nine sites from 6 countries were included. Patients were aged >= 18 years and had UC. Slides were prepared with hematoxylin and eosin staining. A total of 791 images were divided into 2 groups: 630 for training the tool and 161 for testing vs expert histopathologist assessment. The refined AI histology tool utilized a 4-neural network structure to characterize images into a series of cell and tissue type combinations and locations, and then 1 classifier module assigned a Nancy Index score.Results In comparison with the proof-of-concept tool, each feature demonstrated an improvement in accuracy. Confusion matrix analysis demonstrated an 80% correlation between predicted and true labels for Nancy scores of 0 or 4; a 96% correlation for a true score of 0 being predicted as 0 or 1; and a 100% correlation for a true score of 2 being predicted as 2 or 3. The Nancy metric (which evaluated Nancy Index prediction) was 74.9% compared with 72.3% for the proof-of-concept model.Conclusions We have developed a modified AI histology tool in UC that correlates highly with histopathologists' assessments and suggests promising potential for its clinical application. This multicenter study deployed an artificial intelligence tool based on machine learning to scan histopathology slides from ulcerative colitis biopsies and assign a Nancy Histopathology Index. The performance of the tool was similar to that of a panel of expert histopathologists.
Dados da publicação
- ISSN/ISSNe:
- 1078-0998, 1536-4844
- Tipo:
- Article
- Páginas:
- -
- DOI:
- 10.1093/ibd/izae204
- PubMed:
- 39284932
Inflammatory Bowel Diseases Oxford University Press
Citações Recebidas na Web of Science: 9
Citações Recebidas na Scopus: 9
Documentos
- Não há documentos
Filiações
Keywords
- ulcerative colitis; artificial intelligence; histopathology
Projetos associados
Gut microbiome and IBD therapy: an interplay?
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (GutIBD) . 2021
Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (IronIBD) . 2021
Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (4WARD) . 2021
The role of hepatocyte apoptosis markers in predicting the histological and serological activity in steatohepatitis
Investigador Principal: Maria de Fátima Machado Henriques Carneiro
Estudo Clínico Académico . 2021
Isolated Ulceration of Crohn’s Anastomosis
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2022
Burden of Inflammatory Bowel Disease in Portugal
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico (Inflammatory Bowel) . 2023
Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Gastric Cancer Morphological, Immunophenotypic and molecular heterogeneity
Investigador Principal: Maria de Fátima Machado Henriques Carneiro
Estudo Clínico Académico . 2020
Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2019
Citar a publicação
Rubin DT,Kubassova O,Weber CR,Adsul S,Freire M,Biedermann L,Koelzer VH,Bressler B,Xiong W,Niess JH,Matter MS,Kopylov U,Barshack I,Mayer C,Magro F,Carneiro F,Maharshak N,Greenberg A,Hart S,Dehmeshki J,Peyrin L. Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis. Inflammatory Bowel Dis. 2024. IF:4,900. (2).
Portal de investigação
